mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.005 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.005 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |